arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Rapport Therapeutics, Inc.

RAPP Health Care Biotechnology: Pharmaceutical Preparations
$36.10
▼ -3.7% Today
as of Jun 7, 07:25 ET
Last 30 days +6.99% Apr 28 → Jun 05
$32.45 $34.46 $36.47 $38.47 $40.48 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$37.15
High
$37.30
Low
$35.81
Volume
$180,662
Avg Vol
$429,250
Mkt Cap
$1.9B
P/E (TTM)
Beta
52w High
$42.27
52w Low
$10.51
Div Yield
Shares Out
$48M

Overview

52-week range
$11
$42
81% of range
Avg surprise (last 2)
+18.3%
Avg reaction (last 2)
+6.0%
100% positive
Latest IV / EM
127%
EM ±17.6% · $35 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-11.07$-8.41$-5.75$-3.08$-0.42 Actual $-4.45Actual $-5.70Actual $-11.07Actual $-1.70Actual $-0.50Actual $-0.68Est $-0.77Actual $-0.75Actual $-0.71Actual $-0.42Est $-0.56 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-27M$-15M$-3M$9M$21M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.42 $-0.56 +25.0% +38.2% +7.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.71 financials
Mon Jun 30, 2025Jun 2025 $-0.75 financials
Thu May 8, 2025Mar/2025 $-0.68 $-0.77 +11.7% +4.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.50 financials
Sun Jun 30, 2024Jun 2024 $-1.70 financials
Sun Mar 31, 2024Mar 2024 $-11.07 financials
Sat Sep 30, 2023Sep 2023 $-5.70 financials
Fri Jun 30, 2023Jun 2023 $-4.45 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$20M$0
Cost of revenue
Gross profit
Operating income$-24M$-30M$-29M$-27M$-22M$-21M
Net income$-20M$-27M$-27M$-24M$-18M$-18M
EPS (diluted)$-0.42$-0.71$-0.75$-0.68$-0.50$-1.70

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$78M$53M$251M$55M$58M$57M$39M$110M
Inventory
Total current assets$485M$499M$521M$270M$291M$310M$326M$341M
Total assets$498M$512M$535M$285M$302M$315M$331M$346M
Long-term debt
Total liabilities$26M$28M$24M$22M$16M$10M$8M$9M
Total equity$472M$485M$512M$264M$286M$305M$323M$337M

Implied volatility — last 90 days

121%124%126%129%131% Jun 07 — IV 127% · EM ±17.6%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.